$41.45
1.032.55%
Last update: Oct 30, 4:00 PM
Hemab Therapeutics Holdings Inc (COAG) Stock Price, Quote, News & History
COAGNASDAQ
Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported record preliminary unaudited travel bookings of around $4.76...
You can purchase shares of Hemab Therapeutics Hldgs (NASDAQ:COAG) through any online brokerage.
Other companies in Hemab Therapeutics Hldgs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Hemab Therapeutics Hldgs has a consensus price target of $54.71.
The stock price for Hemab Therapeutics Hldgs (NASDAQ: COAG) is $41.45 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Hemab Therapeutics Hldgs.
Hemab Therapeutics Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Hemab Therapeutics Hldgs.
Hemab Therapeutics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann...
